Doxorubicin Hydrochloride

Doxorubicin is an anthracycline topoisomerase II inhibitor indicated for:

Ovarian cancer: After failure of platinum-based chemotherapy.
AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy.
Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy

There are no products to list in this category.